Back to MetLife Investment Management, LLC MetLife Investment Management, LLC

AXSMAXSM
Showing 8 of 29 quarters

Position history for MetLife Investment Management, LLCMetLife Investment Management, LLC's holdings in AXSOME THERAPEUTICS INC

MetLife Investment Management, LLC holds 89,662 shares of AXSM (AXSOME THERAPEUTICS INC), worth $21.9M as of 2026-Q2. The position was decreased (-41.3% shares). AXSM represents 0.1% of MetLife Investment Management, LLC's portfolio.

Current Value

$21.9M

Current Shares

89,662

Total Value Change

+$20.1M

Total Shares Change

+68,617

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
89,662
-41.3%
$21.9M0.1%$244.77
0
2026-Q1
Decreased
152,645
-7.4%
$25.8M0.1%$164.05
0
2025-Q4
Decreased
164,871
-16.4%
$30.1M0.1%$148.79
0
2025-Q3
Increased
197,318
+7.1%
$24M0.1%$117.62
37
2025-Q2
Increased
184,164
+2.9%
$19.2M0.1%$103.36
35
2025-Q1
Increased
178,955
+703.3%
$20.9M0.1%$118.53
55
2024-Q4
Increased
22,277
+5.8%
$1.9M0.0%$84.78
27
2024-Q3
Unchanged
21,045
0.0%
$1.9M0.0%$89.64
0

Other major holders of AXSM: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used